EBOS Group Limited (NZE:EBO)

Market Cap	4.54B -37.1%
Revenue (ttm)	15.12B +3.5%
Net Income	266.03M -6.7%
EPS	1.31 -11.1%
Shares Out	206.92M
PE Ratio	16.77
Forward PE	14.34
Dividend	1.30 (5.85%)
Ex-Dividend Date	Mar 5, 2026

Volume	51,628
Average Volume	367,367
Open	22.05
Previous Close	21.96
Day's Range	22.05 - 23.24
52-Week Range	21.43 - 41.98
Beta	0.18
RSI	41.99
Earnings Date	May 25, 2026

About EBOS Group

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1922
• Employees: 5,800
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: EBO

Financial Performance

In fiscal year 2025, EBOS Group's revenue was 12.27 billion, a decrease of -6.99% compared to the previous year's 13.19 billion. Earnings were 215.14 million, a decrease of -20.77%.

Financial numbers in AUD